ClinicalTrials.gg
Sign In

Adenomyosis clinical trials

The registry lists 142 studies for Adenomyosis across more than 10 countries. 54 are recruiting or about to start. 87 of them are mainly about Adenomyosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.

Get an email when these change. Save the Adenomyosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
39
Recruiting
29
Status unknown
28
Not yet recruiting
22
Active, not recruiting
13
Withdrawn
6

Phase

Phase 3
10
Phase 4
9
Phase 2
8
Early Phase 1
7
Phase 1
3

Where

China
20
United States
16
Italy
14
Egypt
10
France
10
Taiwan
9

Who runs them

Assiut University (6) · Oslo University Hospital (5) · National Taiwan University Hospital (4) · Assistance Publique - Hôpitaux de Paris (4) · University of Texas Southwestern Medical Center (3) · Taipei Veterans General Hospital, Taiwan (3) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (3) · Samsung Medical Center (2)

What is being tested here

Drugs under test in Adenomyosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Gonadotropin-releasing Hormone Analog224
Dienogest204
Ascorbic Acid101
Cyclobenzaprine101
Letrozole101
Nintedanib111
Dextromethorphan101
Leuprolide101
Ulipristal acetate002
Ulipristal002

Coming up

2phase 3 studies under way
11studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 29 Adenomyosis studies recruiting now, 8 (28%) set no upper age limit and 21 (72%) stop at 75 or younger. 2 (7%) take children under 18. 29 (100%) are for women only and 0 (0%) for men only; 9 (31%) take healthy volunteers.

Recruiting studies that take each age, of 29
AgeWomenMen
100 (0%)0 (0%)
1823 (79%)0 (0%)
3029 (100%)0 (0%)
4027 (93%)0 (0%)
5019 (66%)0 (0%)
659 (31%)0 (0%)
759 (31%)0 (0%)
858 (28%)0 (0%)

Across all 142 studies, recruiting or not: 75% stop at 75 or younger and 70% at 65; 9% take children; 99% are for women only and 0% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Adenomyosis studies take

Of 31 observational studies under Adenomyosis, half reached primary completion within 39 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Observational39 mo29–… · 31 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 142. Browse all 142 → or search them.